Kava
•Last Updated: March 6, 2024
Kava (Piper methysticum) is a plant that has had many traditional uses throughout history, especially among South Pacific Islanders. It is best known for anxiety reduction but comes with some serious safety concerns when used in excess.
Kava is most often used for.
Last Updated:March 6, 2024
1.^Ballotin VR, Bigarella LG, Brandão ABM, Balbinot RA, Balbinot SS, Soldera JHerb-induced liver injury: Systematic review and meta-analysis.World J Clin Cases.(2021-Jul-16)
2.^Becker MW, Lourençone EMS, De Mello AF, Branco A, Filho EMR, Blatt CR, Mallmann CA, Schneider M, Caregnato RCA, Blatt CRLiver transplantation and the use of KAVA: Case report.Phytomedicine.(2019-Mar-15)
3.^Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PWFatal fulminant hepatic failure induced by a natural therapy containing kava.Med J Aust.(2003-May-05)
4.^Brauer RB, Stangl M, Stewart JR, Pfab R, Becker KAcute liver failure after administration of herbal tranquilizer kava-kava (Piper methysticum).J Clin Psychiatry.(2003-Feb)
5.^Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah AIn vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.Clin Pharmacol Ther.(2005-May)
6.^Sarris J, Stough C, Teschke R, Wahid ZT, Bousman CA, Murray G, Savage KM, Mouatt P, Ng C, Schweitzer IKava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.Phytother Res.(2013-Nov)
7.^Gurley BJ, Swain A, Hubbard MA, Hartsfield F, Thaden J, Williams DK, Gentry WB, Tong YSupplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.Clin Pharmacol Ther.(2008-Jan)
8.^White CMThe Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava.J Clin Pharmacol.(2018-Nov)
9.^Cagnacci A, Arangino S, Renzi A, Zanni AL, Malmusi S, Volpe AKava-Kava administration reduces anxiety in perimenopausal women.Maturitas.(2003-Feb-25)
10.^Gastpar M, Klimm HDTreatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trialPhytomedicine.(2003 Nov)
11.^Lehrl SClinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trialJ Affect Disord.(2004 Feb)
12.^Thompson R, Ruch W, Hasenöhrl RUEnhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava)Hum Psychopharmacol.(2004 Jun)
13.^R J Boerner, H Sommer, W Berger, U Kuhn, U Schmidt, M MannelKava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patientsPhytomedicine.(2003)
15.^Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer IKava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.J Clin Psychopharmacol.(2013-Oct)
16.^Sarris J, Laporte E, Scholey A, King R, Pipingas A, Schweitzer I, Stough CDoes a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.Traffic Inj Prev.(2013)
17.^Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas SR, Ogden E, Chamoli S, Scholey A, Stough CKava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled studyAust N Z J Psychiatry.(2019 Dec 8)
18.^Sarris J, Kavanagh DJ, Byrne G, Bone KM, Adams J, Deed GThe Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticumPsychopharmacology (Berl).(2009 Aug)
19.^Pittler MH, Ernst EEfficacy of kava extract for treating anxiety: systematic review and meta-analysis.J Clin Psychopharmacol.(2000-Feb)
20.^Kava Kava. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury; USA: National Institute of Diabetes and Digestive and Kidney Diseases, updated April 2018, cited January 2024.(2012)
22.^D D Jamieson, P H DuffieldPositive interaction of ethanol and kava resin in miceClin Exp Pharmacol Physiol.(1990 Jul)
23.^Cairney S, Clough AR, Maruff P, Collie A, Currie BJ, Currie JSaccade and cognitive function in chronic kava users.Neuropsychopharmacology.(2003-Feb)
24.^Cairney S, Maruff P, Clough AR, Collie A, Currie J, Currie BJSaccade and cognitive impairment associated with kava intoxication.Hum Psychopharmacol.(2003-Oct)
25.^Jerome Sarris, David J Kavanagh, Gary Deed, Kerry M BoneSt. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trialHum Psychopharmacol.(2009 Jan)
26.^Herberg KWEffect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters.Blutalkohol.(1993-Mar)
27.^Foo H, Lemon JAcute effects of kava, alone or in combination with alcohol, on subjective measures of impairment and intoxication and on cognitive performance.Drug Alcohol Rev.(1997-Jun)